Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

Some health problems, including chronic pain, inflammation and neurological diseases, can be treated by nerve stimulation, ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence rev ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved ...

SPR announces four featured abstracts that will be presented at the upcoming North American Neuromodulation Society (NANS) Annual Meeting in Orlando 29 – February 1. All the abstracts contain recent ...

OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy ...